Assessment of knowledge, attitude and practices of pharmacovigilance among health care professionals at a tertiary care teaching hospital in Central India
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20254162Keywords:
Pharmacovigilance, Adverse drug reactions, Knowledge, Attitude, Practice, ADR reportingAbstract
Background: Adverse drug reactions (ADRs) are a significant cause of morbidity and mortality worldwide and remain substantially underreported. Pharmacovigilance and spontaneous ADR reporting by health care professionals (HCPs) are critical to identify and mitigate drug-related harm. Our study assessed knowledge, attitude and practice (KAP) regarding pharmacovigilance and explored factors underlying ADR underreporting among HCPs at a tertiary teaching hospital in central India.
Methods: A cross-sectional questionnaire-based survey was administered via Google forms to 160 consenting HCPs (48 doctors, 112 nurses) at a tertiary care teaching hospital. The instrument contained 15 KAP items (5 knowledge-yes/no; 5 attitude-5-point Likert; 5 practice-yes/no) plus a multiple-option item on causes of underreporting. Pretesting, expert validation and Cronbach’s α (0.773) were done. Descriptive statistics were computed.
Results: All doctors (100%) correctly identified ADRs and life-threatening potential; 93.8% recognized that rare ADRs are primarily identified in post-marketing (phase IV) surveillance. Nurses demonstrated high recognition of ADR concept (88.4%) but lower awareness on some specifics (e.g., 67.9% aware that rare ADRs appear in phase IV). Practice differed markedly: while 91.7% of doctors reported routinely encountering ADRs and 89.6% acknowledged ADR documentation, only 16.7% of doctors reported using the covigilance programme of India (PvPI) mobile app; nurses reported substantially lower active reporting behaviours (practice item responses range 6.3-48.2%). Major reasons for underreporting cited were lack of knowledge (doctors 85.4%, nurses 75.0%), difficulty in causality decision (doctors 56.3%, nurses 48.2%), and limited access to reporting forms (doctors 47.9%, nurses 36.6%).
Conclusions: HCPs exhibited satisfactory knowledge and positive attitudes but suboptimal reporting practices, especially among nurses. Interventions such as targeted training, simplified reporting pathways, and institutional pharmacovigilance centres are recommended to improve ADR reporting rates.
Metrics
References
World Health Organization. Safety of medicines: a guide to detecting and reporting adverse drug reactions. Geneva: World Health Organization; 2002. Available at: https://www.who.int/publications/i/item/WHO-EDM-QSM-2002-2. Accessed on 14 May 2025.
Jeetu G, Anusha G. Pharmacovigilance: A worldwide master key for drug safety monitoring. J Young Pharm. 2010;2(3):315-20. DOI: https://doi.org/10.4103/0975-1483.66802
Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol. 2007;7:8. DOI: https://doi.org/10.1186/1472-6904-7-8
Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24(2):46-54. DOI: https://doi.org/10.1023/A:1015570104121
Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol. 1996;42(4):423-9. DOI: https://doi.org/10.1046/j.1365-2125.1996.04376.x
Pathak AK, Kumar M, Dokania S, Mohan L, Dikshit H. A retrospective analysis of reporting of adverse drug reactions in a tertiary care teaching hospital: one year survey. J Clin Diagn Res. 2016;10(8):FC01-4. DOI: https://doi.org/10.7860/JCDR/2016/18826.8284
Bhagavathula AS, Elnour AA, Jamshed SQ, Shehab A. Health professionals’ knowledge, attitudes and practices about pharmacovigilance in India: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0152221. DOI: https://doi.org/10.1371/journal.pone.0152221
Desai C, Panchal J, Dikshit R, Iyer G, Shah S. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011;2(4):129-33. DOI: https://doi.org/10.4103/2229-3485.86883
Tekel MT, Bekalu AF, Sema FD. Knowledge, attitude, and practice of medical, pharmacy, and nursing students towards pharmacovigilance and adverse drug reaction reporting at University of Gondar College of Medicine and Health Sciences, Northwest Ethiopia: a cross-sectional study. Adv Med Educ Pract. 2021;12:1129-39. DOI: https://doi.org/10.2147/AMEP.S327739
Adisa R, Omitogun TI. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria. BMC Health Serv Res. 2019;19(1):926. DOI: https://doi.org/10.1186/s12913-019-4775-9
Khan Z, Karatas Y, Hamid SM. Evaluation of health care professionals’ knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: a cross-sectional multicentral study. PLoS One. 2023;18(5):e0285811. DOI: https://doi.org/10.1371/journal.pone.0285811
Kiyoshi K. Signal Detection from Spontaneous Reports. Jap J Pharmacoepidemiol. 2001;6:101-8. DOI: https://doi.org/10.3820/jjpe1996.6.101
Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385-96. DOI: https://doi.org/10.2165/00002018-200629050-00003
Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci. 2009;31(2):183-7. DOI: https://doi.org/10.1007/s11096-008-9276-6
Parracha ER, Advinha AM, Lopes MJ, Oliveira-Martins S. Mobile apps for quick adverse drug reaction report: A scoping review. Pharmacoepidemiol Drug Saf. 2023;32(1):19-27. DOI: https://doi.org/10.1002/pds.5542
Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19-31. DOI: https://doi.org/10.2165/00002018-200932010-00002
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15-9. DOI: https://doi.org/10.1136/bmj.329.7456.15
Downloads
Published
How to Cite
Issue
Section
